ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in St Louis, MO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Lung Cancer trials near St Louis, MO, USA:

Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: DS-1062a

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Saint Louis, Missouri, United States and 83 other locations

Recently updated

Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer

(CT-STAR) to central and ultra-central early-stage non-small cell lung cancers on grade 3 or greater toxicity. Online adaptive radi...

Enrolling
Non-small Cell Lung Cancer
Early Stage Non-small Cell Lung Cancer
Device: ETHOS
Radiation: Computed tomography-guided stereotactic adaptive radiotherapy
The Washington University
The Washington University

Saint Louis, Missouri, United States

Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer

Study of MGY825 single agent in adult patients with advanced non-small cell lung cancer....

Enrolling
Non-small Cell Lung Cancer
Drug: MGY825

Phase 1

Novartis
Novartis

Saint Louis, Missouri, United States and 12 other locations

An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer

This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small cell lung ...

Active, not recruiting
Non-small Cell Lung Cancer (NSCLC)
Cancer
Drug: Cofetuzumab Pelidotin

Phase 1

AbbVie
AbbVie

Saint Louis, Missouri, United States and 25 other locations

Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (IDeate-Lung01)

results observed in participants with Extensive-stage Small Cell Lung Cancer (ES-SCLC) who received at least 1 prior line of platin...

Active, not recruiting
Extensive-stage Small-cell Lung Cancer
Drug: Ifinatamab Deruxtecan (I-DXd)

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Saint Louis, Missouri, United States and 55 other locations

Study of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung)

The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer. Su ...

Enrolling
Resectable Non-Small-Cell Lung Cancer
Lung Cancer
Drug: Paclitaxel
Drug: Carboplatin

Phase 2

Gilead Sciences
Gilead Sciences

Saint Louis, Missouri, United States and 82 other locations

An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer

in patients with BRAFV600E-mutant metastatic non-small cell lung cancer (NSCLC). Patients who are either treatment-naïve, OR who ha...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: encorafenib
Drug: binimetinib

Phase 2

Pfizer
Pfizer

Saint Louis, Missouri, United States and 157 other locations

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers

In this study, patients with small cell or non-small cell lung cancer will receive ADI-PEG 20, gemcitabine, and docetaxel after dem...

Enrolling
Small-cell Lung Cancer
Non-small Cell Lung Cancer
Drug: ADI-PEG 20
Drug: Docetaxel

Phase 1, Phase 2

The Washington University
The Washington University

Saint Louis, Missouri, United States and 1 other location

Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

The purpose of the study is to determine whether adding vorolanib to atezolizumab will improve the length of time that participants are cancer...

Active, not recruiting
Extensive-stage Small Cell Lung Cancer
Drug: Vorolanib
Drug: Atezolizumab

Phase 2

The Washington University
The Washington University

Saint Louis, Missouri, United States

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (LIVIGNO-4)

Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mortality worldwide, with poor survival ...

Enrolling
Non-Small Cell Lung Cancer
Drug: Carboplatin
Drug: Livmoniplimab

Phase 2, Phase 3

AbbVie
AbbVie

Saint Louis, Missouri, United States and 27 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2024 Veeva Systems